Related Articles
Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement‑positive non‑small cell lung cancer: A case report
Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment
Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A
NO OCCURRENCE OF DNA-POLYMERASE BETA-GENE MUTATION IN HUMAN LUNG-CARCINOMA CELL-LINES WITH K-RAS AS, P53, OR RB GENE ALTERATIONS